Search

Addressing IOP and QOL With LAL, iStent, and Dextenza

I. Paul Singh, MD

Show Description +

I. Paul Singh, MD, discusses the current technologies available to maintain good quality of life (QOL) for patients while also aggressively managing IOP. In this case, the patient had a history of primary open-angle glaucoma and monovision. Dr. Singh demonstrates the implantation of an Light Adjustable Lens (LAL, RxSight) and iStent (Glaukos) with use of Dextenza (dexamethasone ophthalmic insert 0.4 mg, Ocular Therapeutix).

Posted: 2/27/2023

Keywords:

Light Adjustable Lens

•

RxSight

•

iStent

•

Dextenza

Up Next

FLACS With Toric and iStent inject

FLACS With Toric and iStent inject

Blake Williamson, MD, MPH, MS

Targeted Placement of iStent Trabecular Micro-Bypass Stent (Glaukos)

Targeted Placement of iStent Trabecular Micro-Bypass Stent (Glaukos)

Eric Rosenberg, MD

Cataract Surgery Combined with Canaloplasty

Cataract Surgery Combined with Canaloplasty

Mahmoud A. Khaimi, MD

Needle Viscocanalostomy

Needle Viscocanalostomy

Eslam Ramadan, MD

Ahmed M4 Placement

Ahmed M4 Placement

Nathan Radcliffe MD

Hydrogel Sealant to Prevent Chamber Shallowing During Combined Phaco and Tube Shunt Insertion

Hydrogel Sealant to Prevent Chamber Shallowing During Combined Phaco and Tube Shunt Insertion

Ian Conner, MD

Supra-Tenons Baerveldt Glaucoma Drainage Device

Supra-Tenons Baerveldt Glaucoma Drainage Device

George Tanaka, MD

iStent Trabecular Microbypass Implantation Technique

iStent Trabecular Microbypass Implantation Technique

Ike K. Ahmed MD

Trabectome 180

Trabectome 180

Constance Okeke, MD, MSCE

New Directions for GT

New Directions for GT

Arsham Sheybani, MD, Iqbal Ike K. Ahmed, MD, FRCSC

Addressing IOP and QOL With LAL, iStent, and Dextenza

I. Paul Singh, MD

I. Paul Singh, MD, discusses the current technologies available to maintain good quality of life (QOL) for patients while also aggressively managing IOP. In this case, the patient had a history of primary open-angle glaucoma and monovision. Dr. Singh demonstrates the implantation of an Light Adjustable Lens (LAL, RxSight) and iStent (Glaukos) with use of Dextenza (dexamethasone ophthalmic insert 0.4 mg, Ocular Therapeutix).

Posted: 2/27/2023

Keywords:

Light Adjustable Lens

•

RxSight

•

iStent

•

Dextenza

Please log in to leave a comment.

More in Cataract

Innovations in Cataract Surgery: Going Dropless

Innovations in Cataract Surgery: Going Dropless

I. Paul Singh, MD; and Cathleen M. McCabe, MD

Cataract Surgery With a Pre-Existing Filtering Bleb

Cataract Surgery With a Pre-Existing Filtering Bleb

Rachel G. Simpson, MD; and Roya Garakani, DO

Head-to-Head Comparison of Intermediate Vision of Two Monofocal Intraocular Lenses

Head-to-Head Comparison of Intermediate Vision of Two Monofocal Intraocular Lenses

J. Morgan Micheletti, MD

$Visual Outcomes Comparing Emmetropia Versus Mini-Monovision Following Bilateral Implantation of a Non-Diffractive Extended Vision IOL: Randomized Trial$

Visual Outcomes Comparing Emmetropia Versus Mini-Monovision Following Bilateral Implantation of a Non-Diffractive Extended Vision IOL: Randomized Trial

Shail Vasavada, DO, DNB, FICO